Ralph Snyderman - May 27, 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Peter Maag as attorney-in-fact for Ralph Snyderman
Stock symbol
CDNA
Transactions as of
May 27, 2021
Transactions value $
-$761,849
Form type
4
Date filed
6/10/2021, 05:32 PM
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Sale -$159K -1.97K -3.25% $81.01* 58.5K May 27, 2021 Direct F1
transaction CDNA Common Stock Sale -$204K -2.51K -4.29% $81.08* 56K May 28, 2021 Direct F2
transaction CDNA Common Stock Sale -$194K -2.51K -4.48% $77.30* 53.5K Jun 1, 2021 Direct F3
transaction CDNA Common Stock Sale -$205K -2.51K -4.69% $81.57* 51K Jun 2, 2021 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.94 to $81.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.01 to $81.18, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.28 to $77.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.43 to $81.71, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.